{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.179",
  "meta": {
    "versionId": "8",
    "lastUpdated": "2021-09-22T15:50:03.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179",
  "version": "20210720",
  "name": "Bevacizumab Injectable",
  "status": "active",
  "date": "2021-07-20T01:02:12-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "1657066",
            "display": "4 ML bevacizumab 25 MG/ML Injection"
          },
          {
            "code": "1657073",
            "display": "16 ML bevacizumab 25 MG/ML Injection"
          },
          {
            "code": "2046140",
            "display": "16 ML bevacizumab-awwb 25 MG/ML Injection"
          },
          {
            "code": "2046148",
            "display": "4 ML bevacizumab-awwb 25 MG/ML Injection"
          },
          {
            "code": "2268039",
            "display": "4 ML bevacizumab-bvzr 25 MG/ML Injection"
          },
          {
            "code": "2268047",
            "display": "16 ML bevacizumab-bvzr 25 MG/ML Injection"
          }
        ]
      }
    ]
  }
}